Minnema, M C <br/><br/>
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.  [electronic resource] 

 -  Blood  Feb 2000 
 - 1117-23 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antithrombin III--metabolism<br/>Blood Cell Count--drug effects<br/>Blood Coagulation--drug effects<br/>Blood Pressure--drug effects<br/>Drug Administration Schedule<br/>Escherichia coli Infections--blood<br/>Female<br/>Fibrinogen--metabolism<br/>Heart Rate--drug effects<br/>Humans<br/>Inflammation<br/>Interleukin-10--blood<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Male<br/>Papio<br/>Peptide Hydrolases--metabolism<br/>Recombinant Proteins--therapeutic use<br/>Survival<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--metabolism